Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 3 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Royalty Pharma plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 280
- +16 vs. Q4 2021
- Shares held
- 270.5M
- +2.27M (+0.8%) vs. Q4 2021
- Total value
- $10.5B
- −$148.8M (−1.4%) vs. Q4 2021
- New holders
- 52
- 131 more added
- Sold out
- 36
- 59 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 650 | $20.6B |
| Q1 2026 | 594 | $17.0B |
| Q4 2025 | 542 | $13.8B |
| Q3 2025 | 490 | $11.6B |
| Q2 2025 | 458 | $12.4B |
| Q1 2025 | 447 | $9.67B |
| Q4 2024 | 417 | $8.21B |
| Q3 2024 | 396 | $8.85B |
| Q2 2024 | 380 | $8.36B |
| Q1 2024 | 381 | $9.49B |
| Q4 2023 | 364 | $8.74B |
| Q3 2023 | 315 | $8.17B |
| Q2 2023 | 327 | $9.33B |
| Q1 2023 | 338 | $10.9B |
| Q4 2022 | 338 | $11.8B |
| Q3 2022 | 320 | $12.0B |
| Q2 2022 | 286 | $12.3B |
| Q1 2022 | 280 | $10.5B |
| Q4 2021 | 267 | $10.7B |
| Q3 2021 | 234 | $9.59B |
| Q2 2021 | 238 | $10.3B |
| Q1 2021 | 216 | $10.7B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Royalty Pharma plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IBM Retirement Fund | 0 | $0 | 0.00% | −5,424−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −5,194−100.0% | Sold out |
| Concorde Asset Management, LLC | 0 | $0 | 0.00% | −5,168−100.0% | Sold out |
| Islay Capital Management, LLC | 0 | $0 | 0.00% | −3,224−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −2,243−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −620−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −581−100.0% | Sold out |
| TSFG, LLC | 0 | $0 | 0.00% | −351−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −238−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| KRS Capital Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Mystic Asset Management, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Andra AP-fonden | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |